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Most transport pathways between cell nucleus and cyto-
plasm are mediated by nuclear transport receptors of the
importin b family. These receptors are in continuous
circulation between the two compartments and transfer
cargo molecules from one side of the nuclear envelope to
the other. RanBP16 is a family member from higher
eukaryotes of so far unknown function. We now show
that it exports p50RhoGAP from the nucleus and thereby
confines this activity to the cytoplasm. It also accounts for
nuclear exclusion of 14-3-3r, which in turn is known to
anchor, for example, cyclin-dependent kinases in the cyto-
plasm. Our data further suggest that RanBP16 exports
several additional cargoes. It thus appears to be a nuclear
export mediator with broad substrate specificity and we
will therefore refer to it as exportin 7 (Exp7). Finally, we
demonstrate that Exp7-dependent nuclear export signals
differ fundamentally from the leucine-rich, CRM1-depen-
dent ones: First, they are not just short linear sequences,
but instead include folded motifs. Second, basic residues
are critical for Exp7 recruitment.
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Introduction
The nuclear envelope (NE) separates nucleus from cytoplasm
and restricts nucleocytoplasmic exchange of material to
nuclear pore complexes (NPCs). The selectivity of NPCs, in
turn, allows eukaryotic cells to control this trafficking and
hence the composition of the nucleus and the cytoplasmic
compartment. NPCs can be traversed in a passive or a
facilitated manner. The passive mode is efficient for small
molecules but becomes increasingly restricted as the size of
the object exceeds a limit of 20–40 kDa. By contrast, facili-
tated receptor-mediated translocation can accommodate ob-
jects of several MDa and a diameter of nearly 40 nm (for
reviews see Mattaj and Englmeier, 1998; Go¨rlich and Kutay,
1999; Conti and Izaurralde, 2001; Weis, 2003).
The superfamily of importin b-related factors represents
the largest class of nuclear transport receptors (reviewed in
Wozniak et al, 1998; Go¨rlich and Kutay, 1999; Imamoto,
2000; Macara, 2001; Strom and Weis, 2001). Unlike the bulk
of cellular proteins, they can cross the permeability barrier of
nuclear pores rapidly and with little resistance (Ribbeck and
Go¨rlich, 2001). This property allows them to circulate con-
tinuously between nucleus and cytoplasm and to transfer
cargo molecules between the two compartments.
These receptors occur in two flavours, mediators of import
into the nucleus (importins) and export mediators (expor-
tins). Both interact with RanGTP but respond to the nucleo-
cytoplasmic RanGTP gradient (Go¨rlich et al, 1996b, 2003;
Izaurralde et al, 1997; Kalab et al, 2002; Smith et al, 2002)
in diametrically opposed ways. Importins bind cargo at
low RanGTP levels in the cytoplasm and release cargo
upon RanGTP binding in the nucleus (Rexach and Blobel,
1995; Go¨rlich et al, 1996b). In contrast, exportins recruit
cargo at high RanGTP concentrations, as ternary
cargo  exportin RanGTP complexes, in the nuclear compart-
ment and release cargo when the Ran-bound GTP molecule
is hydrolysed in the cytoplasm (Bischoff and Go¨rlich, 1997;
Fornerod et al, 1997; Kutay et al, 1997a). This active control
of cargo binding and release by the RanGTPase system
constitutes the sole input of metabolic energy into these
transport cycles and is sufficient to allow importins and
exportins to accumulate cargoes actively against gradients
of chemical activity (Weis et al, 1996; Kose et al, 1997;
Schwoebel et al, 1998; Englmeier et al, 1999; Ribbeck et al,
1999; Go¨rlich et al, 2003).
In terms of cellular function, it appears useful to distin-
guish four major categories of active nucleocytoplasmic
transport. First, biosynthetic transport, which continuously
supplies one compartment with macromolecules that had
been produced in the other, examples being constitutive
nuclear protein import or export of tRNA, mRNA and ribo-
somal subunits (reviewed in Mattaj and Englmeier, 1998;
Go¨rlich and Kutay, 1999). Second, recycling reactions that
return cargo-free transport receptors or transport adaptors
back to the compartment, in which the next cargo molecule
should be loaded (Kutay et al, 1997a). Nuclear import of Ran
also falls into this category (Ribbeck et al, 1998). Third,
regulated transport, which is used to control key cellular
processes (reviewed in Kaffman and O’Shea, 1999). For
example, numerous transcription factors are held in the
cytoplasm until adequate signals trigger their import and
allow activation or repression of their respective target
genes. Finally, the nuclear export machinery also counteracts
the slow but steady leakage of cytoplasmic proteins into the
nuclear compartment. For example, actin accumulates in the
nucleus, unless expelled from there by exportin 6 (Exp6)
(Stu¨ven et al, 2003). Likewise, CRM1 mediates nuclear ex-
clusion of the translation factors eIF2b, eIF2Be, eIF5 and eRF1
(Bohnsack et al, 2002), while Exp5 keeps eEF1A cytoplasmic
(Bohnsack et al, 2002; Calado et al, 2002).
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While characterising a novel nuclear export pathway, we
identified two additional examples for cytoplasmic proteins,
whose nuclear exclusion is actively maintained: p50RhoGAP
and 14-3-3s. p50RhoGAP is a GTPase-activating protein for
several Rho- and RacGTPases, but attenuation of signalling
by activated (i.e. GTP-bound) Cdc42 appears to be the main
function (Lancaster et al, 1994). Cdc42 in turn regulates
several cellular processes, including actin polymerisation,
cell shape changes, cell growth, endocytosis and vesicular
transport through the Golgi (reviewed in Erickson and
Cerione, 2001; Etienne-Manneville and Hall, 2002). 14-3-3s
is a member of a large protein family. 14-3-3 proteins occur as
dimers and regulate diverse cellular processes, mainly
through binding to phosphorylated ligands (reviewed in Fu
et al, 2000; van Hemert et al, 2001; Tzivion and Avruch, 2002;
Berg et al, 2003). 14-3-3s becomes induced, for example, by
DNA damage and then inhibits cell cycle progression appar-
ently by sequestering CDK/cyclin complexes in an inactive
form in the cytoplasm (Hermeking et al, 1997; Chan et al,
1999; Laronga et al, 2000).
Here we show that RanBP16/Exp7, encoded by the Xpo7
gene, functions as a nuclear export receptor that excludes
p50RhoGAP, 14-3-3s and apparently numerous other proteins
from the nucleus. Exp7 therefore appears to define a general
export pathway, comparable to the CRM1 pathway, and to
play a broad role in maintaining the identities of the nuclear
and the cytoplasmic compartments. We addressed the ques-
tion as to how these different cargoes recruit Exp7 and found
that the critical motif in eIF1 is a short acidic patch followed by
a lysine-rich a-helix. Likewise, basic residues in p50RhoGAP
appear essential for Exp7 binding; they might therefore con-
stitute a general feature of Exp7-dependent export signals.
Results
Identification of Exp7-specific nuclear export cargoes
RanBP16/Exp7 was previously shown to interact specifically
with RanGTP and NPCs, which qualified the protein as a bona
fide member of the importin b family and suggested a
function in nucleocytoplasmic transport (Kutay et al, 2000).
However, Exp7-specific cargoes have not yet been identified
and cellular functions of this receptor have so far remained
elusive. To shed light on this issue, we used immobilised
Exp7 to enrich potential cargoes from a cytoplasmic HeLa cell
extract. As shown in Figure 1, several proteins bound
strongly to Exp7 in the presence of RanGTP, but only weakly
in its absence, and thus represented potential export sub-
strates. Mass spectrometric analysis identified them as
p50RhoGAP, eIF4AI, and the Vps35, Vps26 and Vps29 sub-
units of the mammalian retromer (Haft et al, 2000). All these
factors fulfil cytoplasmic functions and their confinement to
the cytoplasmic compartment through Exp7-mediated nucle-
ar export therefore appeared an attractive possibility.
p50RhoGAP is excluded from nuclei through
a CRM1-independent mechanism
We then generated stably transduced cell lines expressing a
GFP-p50RhoGAP fusion and observed that the protein is well
excluded from nuclei, showing a strong cytoplasmic signal
with significant enrichment at the Golgi (Figure 2). This
localisation is consistent with the function of the
p50RhoGAP substrate Cdc42 in Golgi transport. The inactiva-
tion of the CRM1 export pathway by leptomycin B (LMB)
treatment (Nishi et al, 1994) did not affect this localisation,
suggesting that CRM1 function is not required for nuclear
exclusion of p50RhoGAP (see corresponding panels in
Figure 2). A parallel control verified that the LMB treatment
was effective in shifting the CRM1 cargo eIF2b from an
exclusively cytoplasmic to a predominantly nuclear localisa-
tion (Figure 2; Bohnsack et al, 2002).
p50RhoGAP behaves like an Exp7 substrate
We so far demonstrated the potential of Exp7 to recognise
p50RhoGAP (Figure 1). However, it was unclear to what
extent other exportins would interact with this cargo. To
clarify the issue, we assembled export complexes from a
complete HeLa cell extract onto immobilised p50RhoGAP
and analysed the composition of the bound fraction by
immunoblotting. As expected, Exp7 was enriched strongly
Figure 1 Immobilised human Exp7 was used to recruit potential
transport cargoes from a cytosolic HeLa extract. Binding was in the
absence or presence of 5mM GTP RanQ69L (which mimics a
nuclear environment). Bound proteins were separated by SDS–
PAGE and detected by Coomassie staining. The following putative
export substrates were identified by mass spectrometry:
RhoGTPase-activating protein 1 (p50RhoGAP, NP-004299), eukar-
yotic translation initiation factor 4A-1 (eIF4AI, NP-001407) and
three components of the retromer—human vacuolar sorting protein
35 (hVps35, AAF89953), hVps26 (AAF89954) and hVps29
(AAF89952).
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and in a RanGTP-stimulated manner (Figure 3A). In contrast,
interactions with other export mediators, namely CRM1/
Exp1, CAS/Exp2, Exp4, 5 or 6 (Figure 3A), exportin t or
importin 13 (data not shown), were not detectable.
The binding experiment just mentioned still leaves the
possibility that the Exp7  p50RhoGAP interaction had been
bridged by an additional factor present in the HeLa cell
extract. We therefore repeated the experiment using a differ-
ent source of Exp7, namely a lysate from an Escherichia coli
strain that expressed the recombinant receptor. Also in this
case, Exp7 bound selectively and in a RanGTP-dependent
fashion (Figure 3B). As bacteria lack components of the
nuclear transport machinery, which could possibly have
mediated the cargo  exportin interaction, we can conclude
that Exp7 recognises p50RhoGAP directly and thus behaves
like a nuclear export receptor for this cargo.
Molecular cloning of Xenopus Exp7
We then decided to study nuclear export of p50RhoGAP by
microinjections into the nuclei of Xenopus oocytes. Before
this, however, we had to clarify whether Exp7 exists in
Xenopus oocytes and, if so, how similar to the human protein
it would be. We therefore searched the databases of the
Xenopus laevis and Xenopus tropicalis EST projects (http://
www.sanger.ac.uk), identified partial sequences that
matched various parts of human Exp7 and used this collected
sequence information to amplify the entire coding region
from Xenopus oocyte mRNA by RT–PCR. Sequencing of the
open reading frame revealed 93% amino-acid identity be-
tween human and X. laevis Exp7. Exp7 is thus less conserved
between the two species than is CRM1 (97% identity), but
considerably better conserved than CAS/Exp2 (89% iden-
tity), Exp6 (79% identity) or Exp5 (57% identity). As ex-
pected from the pseudo-tetraploidy of X. laevis, several allelic
isoforms of Exp7 are evident.
Exp7 mediates nuclear export of p50RhoGAP
We next generated affinity-purified antibodies against
Xenopus Exp7 and established by immunoblotting that
Xenopus oocytes contain abundant amounts of the Exp7
protein (E1–2mM cellular concentration, data not shown).
The antibody recognised a single band on blots of total oocyte
extracts (not shown) and can thus be considered monospecific
in immunoblot applications, that is, when the proteins are
presented in a denatured form. We also established that the
antibody recognises native Exp7 (not shown, but see below)
and is thus suitable for selective inhibition experiments.
We then in vitro translated the potential Exp7 cargo
p50RhoGAP in the presence of [35S]methionine and injected
it along with labelled glutathione-S-transferase (GST, a con-
trol protein lacking import or export signals) and an NES-YFP
fusion (a CRM1 export cargo) into the nuclei of Xenopus
oocytes. After 2 h incubation, oocytes were dissected and the
distribution of export cargoes between nuclear and cytoplas-
mic fractions was analysed. While the injection control GST
remained nuclear, a nearly quantitative export of p50RhoGAP
and NES-YFP to the cytoplasm was evident (Figure 4A).
Coinjection of 300 mM of unlabelled NES-YFP competed
with export of the radiolabelled NES reporter, but not export
of p50RhoGAP (Figure 4A). This confirms that p50RhoGAP is
Figure 2 In either stably transduced HeLa or BHK cells, GFP-p50RhoGAP shows a cytoplasmic staining, with some enrichment at the Golgi.
Inactivation of CRM1 by LMB (5 ng/ml) did not change this localisation, even after 20 h of treatment. In contrast, already 1 h of LMB treatment
shifted the CRM1 cargo eIF2b-GFP from exclusively cytoplasmic to mainly nuclear. Images of the paraformaldehyde-fixed samples were taken
by confocal laser scanning microscopy.
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not exported via the CRM1 pathway and also explains why
nuclear exclusion of GFP-p50RhoGAP is not sensitive to LMB
(Figure 2). However, depletion of the nuclear RanGTP pool by
nuclear RanGAP injection abolished the p50RhoGAP export
completely (Figure 4B), indicating that the process is
mediated by a RanGTP-dependent exportin.
We then coinjected the anti-Exp7 antibodies and observed
strong inhibition of p50RhoGAP export (Figure 4C). The effect
was highly specific as judged by two controls: first, anti-Exp7
antibodies did not interfere with export of NES-YFP (Figure 4C)
and, second, anti-CRM1 antibodies inhibited NES-YFP export,
but left export of p50RhoGAP unaffected (not shown). We can
thus conclude that p50RhoGAP is actively confined to the
cytoplasmic compartment and that this confinement is accom-
plished by Exp7-mediated nuclear export.
14-3-3r is also exported by Exp7
In Figure 1, we used immobilised Exp7 to enrich potential
nuclear export cargoes. The added RanGTP also appeared as a
major band in the bound fraction and obscured comigrating
export substrates. To avoid this problem, we employed a
modified binding assay, where we immobilised RanGTP and
assembled export complexes by adding Exp7 and a HeLa cell
extract that had been prior depleted of endogenous transport
receptors. This way, we identified 14-3-3s as a factor that
bound to the RanGTP column in a strictly Exp7-dependent
manner (data not shown).
We next wanted to test if export complex formation of 14-
3-3s is specific for Exp7 (Figure 5A) and therefore performed
a binding experiment using immobilised 14-3-3s as a bait
Figure 3 (A) Nuclear transport receptors were recruited from a
cytosolic HeLa extract to immobilised p50RhoGAP and the beha-
viour of indicated exportins was analysed by immunoblotting. Exp7
bound to p50RhoGAP only in the presence of RanGTP. Binding of
other exportins was not detectable. (B) Binding to immobilised
p50RhoGAP using an E. coli lysate with recombinant human Exp7
as a source of transport receptors. Analysis was by SDS–PAGE
followed by Coomassie staining. Also recombinant Exp7 bound
p50RhoGAP specifically and in a RanGTP-dependent manner. ‘*’
indicates a proteolytic Exp7 fragment.
Figure 4 p50RhoGAP is actively exported from the nuclei of X.
laevis oocytes. (A) 14 nl of a mixture of radiolabelled p50RhoGAP,
NES-YFP and GST (nuclear injection control) was injected into the
nuclei of stage IV–V oocytes. If indicated, 300mM unlabelled NES-
YFP competitor was coinjected. Oocytes were dissected 2 h post-
injection into nuclear (N) and cytosolic (C) fractions and samples
were analysed by 10% SDS–PAGE, followed by autoradiography.
Each time point represents the average of five oocytes. (B) Oocytes
injection was as in (A), but the injection mixture contained
p50RhoGAP, GST and as indicated 10 mM (unlabelled) RanGAP for
depletion of nuclear RanGTP. (C) Anti-Xenopus Exp7 antibodies (at
6 mg/ml in the injection mix) inhibited p50RhoGAP export 21-fold
as compared to the control, where PBS had been coinjected.
Exportin 7
J-M Mingot et al
The EMBO Journal VOL 23 | NO 16 | 2004 &2004 European Molecular Biology Organization3230
and a complete HeLa cell extract as a source of nuclear
transport receptors. No interaction was detectable with the
nuclear export mediators CRM1/Exp1, CAS/Exp2 or Exp4, 5
or 6. However, Exp7 was specifically recruited to the affinity
matrix, provided RanGTP had been added to mimic a nuclear
environment. This RanGTP-dependent binding could also be
reproduced with recombinant Exp7, suggesting that the inter-
action is direct (Figure 5B).
We could not find any evidence for an active nuclear
import of 14-3-3s and also the passive nuclear influx of the
14-3-3s-GFP fusion occurs apparently only very slowly (not
shown). Consistent with this, we observed a cytoplasmic
localisation of the 14-3-3s-GFP fusion and exclusion from
nuclei (Figure 6; see also Hermeking et al, 1997; Chan et al,
1999; Yang et al, 2003; van Hemert et al, 2004). It should be
noted that nuclear exclusion of 14-3-3s is abolished by bulky
N-terminal tags, such as GFP with too short a spacer (not
shown). Such bulky N-terminal fusions interfere also with the
Exp7 14-3-3s interaction (not shown), which in turn sug-
gests that this interaction is relevant for nuclear export.
LMB treatment did not increase the nuclear 14-3-3s signal
(Figure 6), pointing to a CRM1-independent nuclear exclu-
sion mechanism and confirming that CRM1 fails to form
export complexes with 14-3-3s (Figure 5A).
However, microinjection of affinity-purified antibodies
raised against human Exp7 abolished nuclear exclusion and
14-3-3s then showed a clear nucleoplasmic signal with
spared nucleoli (Figure 7). Two lines of control verified the
specificity of this effect. First, injecting the same amount of
antibodies recognising an unrelated antigen did not change
the 14-3-3s localisation (Figure 7). Second, the anti-human
Exp7 antibodies did not increase the nuclear signal of un-
related reporters, such as eEF1A-GFP, eEF1A-GFP-NLS or
eIF2b-GFP (not shown), which are excluded by Exp7-inde-
pendent mechanisms (Bohnsack et al, 2002).
We finally tested the behaviour of 14-3-3s in the Xenopus
oocyte system. When injected into nuclei, only slow export
occurred (Figure 8) and this slow export was completely
abolished by coinjection of anti-Xenopus Exp7 antibodies
(not shown). Conversely, export was B10-fold stimulated
by coinjection of recombinant Exp7, whereas coinjection of
CRM1 at the same concentration had no effect (Figure 8).
Exp7 is thus required and sufficient for 14-3-3s export from
both mammalian and Xenopus nuclei.
The export signal in p50RhoGAP is multipartite
14-3-3s and p50RhoGAP are very different in function and
structure (Liu et al, 1995; Xiao et al, 1995; Barrett et al, 1997);
they share no regions of significant homology. Yet, Exp7
Figure 5 (A) Cognate nuclear export receptors were recruited from
a cytosolic HeLa extract to an immobilised 14-3-3s-zz fusion.
Analysis was by immunoblotting. Exp7 bound to 14-3-3s only in
the presence of RanGTP (5mM); binding of other exportins was
undetectable. (B) Binding assay was performed as in (A), but an E.
coli lysate with recombinant Exp7 was the source of transport
receptors.
Figure 6 In either stably transduced BHK and HeLa cell lines, 14-3-3s-GFP shows a cytoplasmic localisation. This did not change by
incubating the cells for 1 or 20 h with LMB (5 ng/ml). For controls, see Figure 2.
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recognises both of them as cargoes, and this poses the
question for the corresponding nuclear export signals
(NESs). To gain a first insight into this issue, we tested
which parts of p50RhoGAP interact with the exportin. We
found that at least three regions, namely the extreme N-
terminus (residues 1–64), an internal fragment (residues
198–257) and the C-terminal RhoGAP domain (residues
257–439), play a role (see Supplementary data), although
none of these is sufficient for a high-affinity interaction. In
contrast to the CRM1-dependent leucine-rich NESs, the ex-
port signal in p50RhoGAP comprises therefore not just a
single linear sequence. Instead, it is multipartite and includes
at least one motif that is presented by the compactly folded
RhoGAP domain, which, in turn, cannot be dissected further
without disrupting folding.
Such complex NESs are very difficult to map and a
complete description of the signal would probably require
solving the structure of the p50RhoGAP Exp7 RanGTP com-
plex (as a side note it should be mentioned that not a single
complex NES has been elucidated so far). In the meantime,
however, we had identified numerous other proteins that
bind to Exp7 in a RanGTP-dependent fashion and we chose
the smallest of them, the translation initiation factor eIF1
(Supplementary Figure 1; see also Pestova and Kolupaeva,
2002; Majumdar et al, 2003, and references therein), for
further analysis.
The Exp7-binding motif in eIF1 consists of aspartates
and a lysine-rich a-helix
The solution structure of eIF1 has been solved by NMR
(Fletcher et al, 1999). eIF1 consists of an extended N-terminal
region, which we found to be dispensable for Exp7 binding
(see Figure 9A), and a compactly folded C-terminal domain.
This compactly folded domain contains 36 highly solvent-
exposed residues, which were all candidates for making
contacts to Exp7. We found that yeast eIF1 is also recognised
by Exp7 (Figure 9A). Residues that are essential for Exp7
binding are therefore likely to be conserved between the two
species. By this consideration, 19 charged residues remained
as immediate candidates (Figure 9B).
With a first round of mutagenesis on human eIF1, we
established that H32, R34, R38, R41, E78, R90, K91, K109 and H111
Figure 7 HeLa cells expressing 14-3-3s-GFP were microinjected
with affinity-purified anti-human Exp7 or control antibodies (anti-
Drosophila Exp5), and fixed 18 h later. In anti-Exp7-injected cells,
14-3-3s-GFP equilibrated between nucleus and cytoplasm and
showed a clear nucleoplasmic signal with spared nucleoli. By
contrast, the GFP fusion remained strictly excluded from the nuclei
of noninjected cells or cells injected with the control antibody.
Injected cells (indicated by ‘*’) were identified by immunofluores-
cence detecting the injected antibody in the Red channel. Images
were taken by sequential confocal scans detecting GFP and the
Alexa 568-labelled secondary antibody.
Figure 8 35S-labelled 14-3-3s and GST were generated by in vitro
translation and injected into the nuclei of Xenopus oocytes. After
2 h, oocytes were dissected and the nucleocytoplasmic distribution
of the two proteins was determined by SDS–PAGE followed by
autoradiography. Coinjection of 15 mM human Exp7 stimulated
14-3-3s export 10-fold but had no effect on GST.
Figure 9 (A) An E. coli lysate containing recombinant human Exp7
was incubated with immobilised full-length human eIF1
(FL¼ residues 1–114), yeast eIF1 (FL¼ residues 1–108) or indicated
eIF1 fragments. Binding was in the presence of 5mM GTP RanQ69L.
(B) Alignment of the compactly folded domains from human (H.s.)
and yeast (S.c.) eIF1. Highly solvent exposed residues (*) and
residues mutagenised (.) in panel C are indicated. Critical residues
for Exp7 binding are underlined. (C) Wild-type (wt) or indicated
mutant forms of human eIF1 were immobilised and used to bind
Exp7 from complete cytosolic HeLa extract in the presence of 5 mM
GTP RanQ69L. Bound Exp7 was detected by immunoblot.
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do not detectably contribute to Exp7 binding (see binding
assays in Figure 9C). In contrast, the D52D53-RR, D55-R,
K57K65-EE and K64K65-EE mutations strongly reduced or
even abolished the interaction. These crucial positions are in
close proximity to each other. To map the signal at a single-
amino-acid resolution, we finally mutagenised each of the
exposed residues in this region and thereby identified a total
of eight residues that are critical for Exp7 binding: D52, D53,
D55, K56, K58, K64, K65 and K66 (Figure 9C, lower part). These
critical residues are arranged in a very characteristic motif,
namely a short, acidic extended region followed by an
amphipathic helix, in which all hydrophilic, solvent-exposed
residues are lysines and where the hydrophobic ones pack
against the hydrophobic core of the domain (Fletcher et al,
1999).
The just described Exp7-binding motif follows, however,
no rigid consensus. Instead, it appears that an unfavourable
residue in one position can be compensated somewhere else
in the molecule. This is exemplified by yeast eIF1, where the
critical K56 is substituted by leucine and K66 by aspartic acid.
Yet, yeast eIF1 binds Exp7, and its lower affinity becomes
only apparent when eIF1 competes with other cargoes for
Exp7 binding (not shown).
Positively charged residues appear to be a general
feature of the Exp7 export signature
The binding data with eIF1 raised the possibility that posi-
tively charged residues mediate Exp7 binding also in other
cargoes. To test this assumption, we mutated several basic
patches in p50RhoGAP (Figure 10). None of the mutations
interfered with folding as judged from the fact that the
bacterially expressed mutant proteins were as soluble as the
wild-type form. Three basic patches, namely R83K84, K152K153
and R282R283, turned out to be critical for the recruitment of
Exp7 (see Figure 10). This loss of interaction was not just a
matter of total charge, as mutating other basic residues
(R149K150 or K156) had no effect. We do not yet know how
the complete export signal in p50RhoGAP looks like; how-
ever, the data clearly indicate that positively charged patches
are a genuine part of the signature by which Exp7 selects
cargoes. Exp7-dependent export signals therefore differ fun-
damentally from CRM1-dependent ones.
Discussion
A major goal of the nucleocytoplasmic transport field has
been to obtain a comprehensive overview of the cellular
nuclear transport pathways. In the yeast Saccharomyces
cerevisiae, 13 importin b-type nuclear transport receptors
are known and functions have been allocated to 12 of them
(Fried and Kutay, 2003). The repertoire of higher eukaryotes
is larger and comprises, for example, 20 family members in
human cells. A total of 10 family members have been known
to function in import, six in export and one in both. With this
study, we have elucidated a novel human pathway and
demonstrated that RanBP16/Exp7 represents a bona fide
nuclear export receptor for at least two cytoplasmic proteins,
p50RhoGAP and 14-3-3s.
Nuclear export of 14-3-3s was previously suggested to be
CRM1 dependent (Brunet et al, 2002; van Hemert et al, 2004).
Our data argue against such scenario: 14-3-3s directly binds
to Exp7 but not detectably to CRM1 (Figure 5); export is
inhibited by blocking Exp7 (Figure 7) but not by inactivating
CRM1 (Figure 6); and, finally, export is stimulated by exo-
genous Exp7 but not by CRM1 (Figure 8). How can these
different conclusions be explained? One could assume that
the problem originates, at least in part, from the use of LMB
as a sole assessment. LMB selectively inactivates CRM1, but
the consequences of this inactivation are ultimately lethal
(Nishi et al, 1994) and thus pleiotropic. The exclusively
cytoplasmic localisation of RanBP1 and RanGAP, for example,
requires CRM1 (Richards et al, 1996 and our unpublished
data). LMB will therefore impair the nucleocytoplasmic
RanGTP gradient and thereby indirectly inhibit also those
nuclear transport pathways that operate in parallel to CRM1.
This could well explain why LMB could raise, under certain
conditions, the nuclear concentrations of 14-3-3s. Given the
just described experience with 14-3-3s, we would not be
surprised if numerous other export events, which were pre-
viously attributed to CRM1, are in fact mediated by another
transporter, such as Exp7.
Typical importins, such as importin b, transportin, impor-
tin 5 or importin 7, have a broad substrate specificity and are
apparently able to transfer a large number of distinct cargoes
into the nucleus. In contrast, most exportins appear specia-
lised on a narrow group of cargoes or even on a single highly
abundant export substrate, examples being CAS/Exp2, which
retrieves importin a from the nucleus (Kutay et al, 1997a),
exportin t, which mediates tRNA export (Arts et al, 1998;
Kutay et al, 1998), Exp4, which exports eIF5A (Lipowsky et al,
2000), or Exp6, which exports actin from the nucleus (Stu¨ven
et al, 2003). CRM1 has so far been the only exception; it
accounts for the export of several distinct RNPs and a large
number of proteins or protein complexes (reviewed in
Fornerod and Ohno, 2002; see also Tschochner and Hurt,
2003). It can thus be considered as a broad-spectrum expor-
tin. Exp7 appears now to be the second example of an
exportin with broad substrate specificity and we show in
this study that it accounts for export of p50RhoGAP and
nuclear exclusion of 14-3-3s. The binding data from
Figure 1 further suggest that it is also involved in nuclear
export of eIF4AI and the retromer complex. In addition, we
have preliminary evidence for a role of Exp7 in nuclear export
of at least 12 further components (our unpublished observa-
tions).
The Exp7 cargoes described in this study are unrelated by
sequence, structure and function and, yet, they are all recog-
nised by this exportin. CRM1 also recognises many different
cargoes, most of them through a small, transplantable pep-
tide motif, the leucine-rich NES (Fischer et al, 1995; Wen et al,
Figure 10 Immobilised p50RhoGAP wild type or the indicated
variants were incubated with a complete cytosolic HeLa cell extract
in the presence of 5mM GTP RanQ69L. Bound Exp7 was detected
by immunoblot.
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1995; Bogerd et al, 1996). This raised the question as to
whether Exp7 recognises an analogous motif. We have ad-
dressed this question first for eIF1, the so far smallest known
protein that binds Exp7 in a RanGTP-dependent fashion. We
found that in this case a highly charged motif is recognised:
D52 DYDKKKLVKAFKKK66, whereby the underlined aspartic
acid and lysine residues are required for a high-affinity
interaction. This motif shows a characteristic fold. The acidic
patch is extended, while the rest folds into an a-helix, such
that the lysines are exposed to the solvent and the hydro-
phobic residues pack against the hydrophobic core of the
domain (see Fletcher et al, 1999). Even though the binding
motif is a comparably small peptide (16 residues), its fusion
to a reporter protein is unlikely to be sufficient to confer Exp7
binding, simply because folding probably requires the context
of the entire domain.
eIF1 (12.7 kDa) is so small that it traverses NPCs faster
than typical transport receptor  cargo complexes, and we
could not so far directly demonstrate that Exp7 confines
eIF1 in the cytoplasm. This could just reflect technical
complications. On the other hand, it is not certain that the
eIF1 Exp7 RanGTP complex represents an export complex.
It could as well form for a different reason, such as to directly
quench eIF1 activity in the nuclear compartment and thus to
suppress nuclear translation. In any case, it gave the hint that
basic residues might be of general importance for cargo
recognition by Exp7. However, the export signal in
p50RhoGAP appears far more complex than the Exp7-binding
site in eIF1. We have identified at least four distant regions of
p50RhoGAP, which are required to recruit Exp7, namely three
basic clusters (R38K84, K152K153 and R282R282; Figure 10) and
the extreme N-terminus (residues 1–64; see Supplementary
data). These data suggest that Exp7 recognises this cargo
through multiple low-affinity interactions.
Out of the human 14-3-3 paralogues, the s isoform is an
Exp7 substrate (Figures 5–8), while 14-3-3b and z are not
(our unpublished data). Thus, Exp7 does not just recognise
the fold of 14-3-3 proteins but also regions of 14-3-3s, which
differ from the b and z isoforms. As expected from the eIF1
and p50RhoGAP signals, our preliminary data suggest that at
least one basic patch in 14-3-3s is involved in Exp7 binding.
p50RhoGAP, 14-3-3s and the putative cargoes eIF4AI and
the mammalian retromer fulfil, as far as we can tell, cyto-
plasmic functions only. eIF4AI mediates initiation of transla-
tion (reviewed in Pestova et al, 2001; Rogers et al, 2002).
p50RhoGAP regulates Cdc42 activity (Lancaster et al, 1994).
14-3-3s arrests the cell cycle, for example, after DNA damage
by sequestering CDKs in the cytoplasm (Hermeking et al,
1997; Chan et al, 1999; Laronga et al, 2000), and the retromer
mediates retrograde vesicular transport from the yeast pre-
vacuolar compartment or the endosome of higher eukaryotes
to the Golgi (see Arighi et al, 2004; Seaman, 2004, and
references therein).
The nuclear exclusion of these components makes perfect
biological sense; however, it poses the question as to why
nuclear exclusion is not just achieved by a lack of active
nuclear import. This could be because of the following three
reasons: first, these factors might have cryptic import signals,
such as a 14-3-3 ligand that contains a bona fide NLS. Second,
the open mitosis in higher eukaryotes causes mixing of
cytoplasmic and nuclear contents, which need to be re-
separated after return to interphase conditions. Finally, not
even in interphase, NPCs represent absolute barriers
(Ribbeck and Go¨rlich, 2001) and so leakage of any given
cytoplasmic protein into the nuclear compartment is just a
matter of time. Although protein synthesis takes place in the
cytoplasm, it appears that an exclusive cytoplasmic localisa-
tion does not occur by default, but instead depends on
cytoplasmic sorting signals, which in many cases confer
exportin-mediated nuclear export. In fact, one should expect
the number of proteins, which are actively excluded from the
nuclear compartment, to be very large, possibly in the order
of several or many thousands. How the nuclear export
machinery should recognise such an extremely diverse set
of proteins is yet unclear, but CRM1 and Exp7 are likely to
play a key role.
Materials and methods
Expression constructs
The coding regions of the various proteins used in this work have
been amplified by PCR using primers with appropriate restriction
sites. Human and Xenopus Exp7 were amplified from HeLa and X.
laevis cDNA, respectively, p50RhoGAP, 14-3-3s and human eIF1
from clones obtained from the Resource Centre/Primary Database
(RZPD), yeast eIF1 from S. cerevisiae complete genomic DNA and
GST from pGEX-4T-1 (Amersham Biosciences).
The following vectors have been used in this work. For bacterial
expression, four derivatives of pQE-80 (Qiagen) are used: pNhis1080
(provides an N-decahis tag), pChis1080 (provides a C-decahis tag),
pNzztev80 (provides N-zz and C-hexahis tags) and pCzz80
(provides a C-zz-hexahis tag). For expression in mammalian cells,
two derivatives of pRevTRE2 (BD Biosciences) are used: pNGFPrev
and pCGFPrev (which provide N-GFP and C-GFP tags, respectively).
For in vitro transcription–translation, pT7-60 (Go¨rlich et al, 1996a)
was used. This vector contains a T7 promoter and a b-globin 50UTR
for improved translation.
Human Exp7 was cloned in pNhis1080 and pNzztev80, Xenopus
Exp7 in pNhis1080, p50RhoGAP in pNGFPrev, pNzztev80 and
pT760, 14-3-3s in pCzz80, pCGFPrev and pT7-60, yeast and human
eIF1 in pNzztev80 and GST in pT7-60.
DNA coding for NES-YFP (a fusion between the NES of PKI (Wen
et al, 1995) and EYFP) was cloned in pChis1080 and pT7-60.
All constructs were verified by DNA sequencing.
Protein expression and purification
Expression and purification of CRM1, RanQ69L and Rna1p
(RanGAP) have been described previously (Izaurralde et al, 1997;
Kutay et al, 1997b; Stu¨ven et al, 2003). His-tagged proteins (human
and Xenopus Exp7 and NES-YFP) were expressed in E. coli and
purified by Ni-NTA agarose followed by gel filtration on Superdex
200. zz-tagged proteins (human Exp7, p50RhoGAP, yeast and
human eIF1 and 14-3-3s) were expressed in E. coli and immobilised
directly from the 100 000 g cleared lysates to IgG-Sepharose.
In vitro transcription–translation
In vitro transcription–translation of p50RhoGAP, NES-YFP, 14-3-3s
and GST was performed from the corresponding T7 promoter
constructs in the presence of [35S]methionine (Amersham) using
the TNT reticulocyte lysate system (Promega). Reactions were
performed at 301C for 90 min in a 50ml volume and stopped by
adding 250ml of ice-cold PBS. In order to remove free [35S]methio-
nine and concentrate the proteins, the final volume of the samples
was reduced to 15–20 ml by centrifugation through Nanosep
Cenrifugal Devices (PALL Corporation) with a 10 kDa cutoff.
Samples were then aliquoted and either frozen or directly used
for oocyte microinjections.
Oocyte injection and analysis
Collagenase-treated X. laevis oocytes were prepared and injected as
described before (Jarmolowski et al, 1994). After indicated time
points, oocytes were dissected, proteins of the nuclear and
cytoplasmic fractions precipitated and finally analysed by SDS–
PAGE and autoradiography.
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Binding assays
zz-tagged proteins were immobilised to IgG-Sepharose. A 25 ml
portion of immobilised protein was incubated for 3 h, either in the
absence or presence of 5mM of purified GTP RanQ69L (a GTPase-
deficient mutant), with 0.8 ml of HeLa extract or a 100 000 g cleared
lysate from an E. coli strain that expressed recombinant human
Exp7 (both lysates adjusted to 50 mM Tris–HCl pH 7.5, 50 mM NaCl,
10 mM MgCl2). Bound proteins were eluted with 1.5 M MgCl2,
50 mM Tris–HCl pH 7.5, precipitated with 95% isopropanol,
separated by SDS–PAGE and analysed by Coomassie staining or
Western blotting.
Antibodies
All antibodies have been raised in rabbits and affinity purified on
their respective immobilised antigens. Antibodies against human
and Xenopus Exp7 were raised against C-terminal peptides.
Antibodies against human Exp6 and mouse Exp4 were raised
against the recombinant protein. Antibodies against CRM1, CAS/
Exp2 and Exp5 have been described previously (Mingot et al, 2001;
Bohnsack et al, 2002).
Microinjection of antibodies into mammalian cells and
immunofluorescence
HeLa and BHK stable cell lines expressing 14-3-3s-GFP or GFP-
p50RhoGAP were generated by retroviral transduction, as described
before (Bohnsack et al, 2002), using the appropriate pRevTRE2
constructs. The BHK stable cell line expressing eIF2b-GFP has been
described before (Bohnsack et al, 2002).
Expression of the GFP-tagged proteins was induced with 100 ng/
ml doxycycline for 18 h at 371C and 5% CO2. Cells were then either
fixed immediately or fixed after indicated incubations or micro-
injection with antibodies.
Microinjections of antibodies (6 mg/ml) were performed with the
AIS 2 system (CellBiology Trading), which controls an Eppendorf
Femtojet that is mounted onto a Zeiss Axiovert inverse microscope.
After 18 h incubation at 371C and 5% CO2, the cells were fixed and
the injected antibodies were immunostained with an Alexa 568-
labelled goat anti-rabbit antibody (Molecular Probes) following a
protocol previously described (Bohnsack et al, 2002). Green and red
fluorescence signals were then sequentially recorded with an SP2
confocal laser scanning microscope (Leica).
Fixation was performed in all cases at 371C with 3%
paraformaldehyde in PBS for 15 min.
Site-directed mutagenesis
Indicated mutations were introduced into the coding sequences of
eIF1 (Figure 9) and p50RhoGAP (Figure 10) by the PCR-based
QuickChange method (Stratagene). Plasmid DNA was purified from
single clones and the presence of the mutations (as well as the
absence of undesired mutations) was verified by DNA sequencing.
DDBJ/EMBL/GenBank accession no.
The nucleotide sequence of X. laevis Exp7 is listed under accession
number AJ620730.
Supplementary data
Supplementary data are available at The EMBO Journal Online.
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